Draft, not yet released. In stewardship review. Not indexed until the first approved release.

Data appendix

The indicator set with its sources, the source registers, the licences of every kind of material and the formats of the edition.

10 min read0 figures8 tables17 notesNR-XTECH-NEURO-GLOBAL-2026-BASELINE

Contents
  1. ·Edition home
  2. ·Executive summary
  3. 1Neurotechnology is clinical hardware and a new class of personal data
  4. 2Key findings
  5. 3Systems and sectors at baseline
  6. 4Risks and capability
  7. 5Consumer neural data outside medical rules
  8. 6Readings from the other desks
  9. 7The 2027 agenda
  10. 8Systems in depth
  11. AMethodology
  12. BData appendix
    1. B.1 The indicator set
    2. B.2 Global source register
    3. B.3 Regional reading, neurotechnology across ten clusters
    4. B.4 Cluster card: speech neuroprosthesis research network
    5. B.5 How countries appear in the neurotechnology edition
    6. B.6 Licences
    7. B.7 Formats and provenance
  13. CReferences and record
  14. ·Complete edition, for print

B.1The indicator set

Table B.1Global baseline indicator set
IndicatorValueUnitYearStateSource
Speech decoding rate, large vocabulary62words per minute2023Reported1
Word error rate, 125,000 words23.8%2023Reported1
Word error rate, 50 words9.1%2023Reported1
Median speech decoding rate78words per minute2023Reported2
Median word error rate25%2023Reported2
Accuracy beyond eight months, 125,000 words97.5%2023Reported3
Electrodes in the accuracy study256electrodes2023Reported3
Handwriting decoding rate90characters per minute2021Reported6
Participants in the inner speech study4participants2025Reported5
Participants in the endovascular study5participants2025Reported8
Channels in the endovascular array16channels2025Reported8
Estimated enrolment in PRIME15participants2026Reported13
Participants implanted, company statement5participants2025Reported20
Neuralink round650USD million2025Reported20
FTC study authorisation in the MIND Act10USD million2025Reported11
Maximum implantation duration in the cleared array30days2025Reported15

B.2Global source register

The governed source set behind this edition. Each source keeps its authority, coverage, cadence and role; categories describe origin, not truth.

Domains bound by the register

  • INF
  • DAT
  • HLT
  • FIN
  • GOV
  • BIO
  • TRD
  • MIN
  • ENE
  • AIC
Table B.3Global source register
SourceCategoryCoveragePeriodCadenceRole
Willett et al. in Nature1peer-reviewed journalone participant2023one-offspeech decoding
Metzger et al. in Nature2peer-reviewed journalone participant2023one-offspeech and avatar
Card et al. record3preprint server recordone participant2023one-offaccuracy
Kunz et al. in Cell5peer-reviewed journalfour participants2025one-offinner speech
Lorach et al. in Nature7peer-reviewed journalone participant2023one-offbrain-spine interface
Chetty et al.8preprint serverfive participants2025one-offendovascular
FDA guidance9national regulatorUS2021one-offtesting
UNESCO page10intergovernmental bodyglobal2025one-offethics
Registry entry13trial registryone study2026continuousenrolment
Chinese implementation opinion, translated16translation of a ministry textChina2025one-offtargets

B.3Regional reading, neurotechnology across ten clusters

Regional plates follow with the regional editions. This page gives the regional reading of neurotechnology and neural data in table form and ranks no region.

Table B.4Regional reading, neurotechnology across ten clusters
RegionPrincipal hazardsSystems most exposedBaseline evidence
North Americaclinical trials; federal guidance; state neural data lawsdevices, data lawFDA9; Colorado14; Senate11
South Americaconstitutional neurorights in Chiledata lawChilean sources1718
Europemedical device rules and research programmesregulationregional evidence (not bound)
Eurasiaresearch programmesresearchregional evidence (not bound)
Middle East and North Africano evidence boundnot boundregional evidence (not bound)
Africaaccess and skillsworkforceregional evidence (not bound)
South Asiano evidence boundnot boundregional evidence (not bound)
East Asiaindustrial policy targets for 2027 and 2030industry policyChinese opinion16
ASEANno evidence boundnot boundregional evidence (not bound)
Oceania-Pacificno evidence boundnot boundregional evidence (not bound)

B.4Cluster card: speech neuroprosthesis research network

  • speech
  • intracortical arrays
  • single participants
  • inner speech
Systems in view
implanted arrays, decoders, clinical teams, participants with paralysis
Defining events
two Nature papers of August 202312
Couplings
INF → HLT clinical benefit; INF → DAT inner speech
Capability evidence
long-term accuracy and inner speech safeguards reported35
Gaps
participants beyond one or four; home use; durability
Agenda items
N-04 · N-05

Speech decoders reached 62 and 78 words per minute in single participants with paralysis [1] [2].

CLINIC

Speech from attempted speaking

Imagined sentences were decoded in four participants, and the authors propose safeguards against unintended decoding [5].

DATA

Inner speech

Accuracy of 97.5% beyond eight months was reported for one participant; drift remains a studied problem [3] [22].

DURABILITY

Months after implantation

B.5How countries appear in the neurotechnology edition

Countries enter the neurotechnology edition through the readiness chapters of their own national editions, on one card grammar. They are read against peer distributions and thresholds, never ranked.

Table B.5How countries appear in the neurotechnology edition
Card fieldWhat it showsSource
WEFH+B stateeach core system against peer distribution bandsnational edition
Couplingsthe national dependency matrixnational edition
Risk objectsthe national risk portfolionational edition
Capability rungsthe national capability laddernational edition
Evidence ageoldest and newest source datesnational source register

Editions in the 2026 Baseline programme

26national

countries and unions

10regional

clusters

16global

flagship and sector

14strategic

systems reports

20frontier

technology reports

How to read a country card

  • Each system is shown against the distribution of its peers, with thresholds where they exist
  • Couplings and risk objects come from the country’s own national edition
  • Capability rungs record evidence, not a judgement of institutions
  • Evidence age is printed, so older national data are visible as such
Table B.6National Baseline Editions in the 2026 programme
WaveCountries and unionsState
W0CanadaISSUED
W1United States, United Kingdom, France, Germany, Italy, Japan, European Union, SwitzerlandPLANNED
W2Mexico, Brazil, Argentina, Türkiye, Russian Federation, Saudi Arabia, United Arab Emirates, South Africa, Senegal, Kenya, African Union, India, China, Republic of Korea, Indonesia, Singapore, AustraliaPLANNED

B.6Licences

Table B.7Licences of each kind of material
MaterialLicence
TextCC BY 4.0
Dataon the licence of each source; Nexus tables CC BY 4.0
FiguresNexus figures CC BY 4.0; third-party as credited
Mapsboundary source and licence printed on each plate
MetadataCC0 1.0, as Zenodo publishes it
Third-party data, figures and textThe source’s own licence, credited where it is used; never relicensed
Nexus-authored text, tables and figures: CC BY 4.0 (SPDX CC-BY-4.0). Map plates print their boundary source and licence.

B.7Formats and provenance

Table B.8This edition in every format
FormatKindStateWhat it isIdentifier
Web editionHTMLOn this siteDraft in stewardship review; every value resolves to its source.NR-XTECH-NEURO-GLOBAL-2026-BASELINE-v1.0.0
Print editionPDFAt releaseA4 portrait · screen, print and archival PDF, signed with the web edition at release.NR-XTECH-NEURO-GLOBAL-2026-BASELINE-v1.0.0
Indicator dataCSV · JSONOn this site16 indicators with unit, year, status and source; the machine-readable copy ships with the evidence bundle at release.NR-XTECH-NEURO-GLOBAL-2026-BASELINE data release v1
FiguresSVG · PNGOn this site4 on the web edition: headline figure, figure 1.3, coupling instrument, capability ladder.FIG-XTECH-NEURO-GLOBAL-2026-BASELINE-*
SlidesPDFNot recordedNo slide deck is recorded for this edition.
Evidence briefHTML · PDFNot recordedNo evidence brief is recorded for this edition.
Dataset with DOIDataCiteAt releaseConcept and version DOI are minted at deposit; none is recorded yet.

Provenance

Edition pack
The edition’s content pack (JSON), from which the print and web editions are built
Evidence cut
DC-XTECH-NEURO-GLOBAL-2026-B0, closed 30 September 2026
Reproducibility
sourced values cited; analytical values reproducible from stated parameters
Self-check
14 of 23 at evidence close; a fail on any item blocks release
Review
five passes scheduled before release (in Annex C)
Publisher of record
The Global Centre for Risk and Innovation (GCRI) for the Nexus Consortium
Corrections
Registry correction pathway; upheld corrections are published as notices with a new version

Notes

Numbers are the edition’s reference numbers, so a note reads the same in every chapter. The full list, with every source and its licence, is in Annex C. Annex C, references

  1. 1Willett, F.R. et al., A high-performance speech neuroprosthesis, Nature 620(7976), 1031 to 1036, published online 23 August 2023 (reference record read: 62 words per minute; 23.8% word error rate on 125,000 words; 9.1% on 50 words). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
  2. 2Metzger, S.L. et al., A high-performance neuroprosthesis for speech decoding and avatar control, Nature 620(7976), 1037 to 1046, published online 23 August 2023 (reference record read: median 78 words per minute; median word error rate 25%). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
  3. 3Card, N.S. et al., An accurate and rapidly calibrating speech neuroprosthesis, medRxiv preprint, 26 December 2023 (preprint record read: 99.6% on 50 words on day 1; 90.2% on 125,000 words on day 2; 97.5% beyond eight months; 256 electrodes; the record notes the New England Journal of Medicine version 391(7), 609 to 618, August 2024). Cold Spring Harbor Laboratory, New York. Observation year 2023. Accessed 2026-11-03.back
  4. 6Willett, F.R., Avansino, D.T., Hochberg, L.R., Henderson, J.M. and Shenoy, K.V., High-performance brain-to-text communication via handwriting, Nature 593(7858), 249 to 254, published online 12 May 2021 (reference record read: 90 characters per minute; 94.1% raw online accuracy). Springer Nature, London. Observation year 2021. Accessed 2026-11-03.back
  5. 5Kunz, E.M. et al., Inner speech in motor cortex and implications for speech neuroprostheses, Cell 188(17), 4658 to 4673, published online 14 August 2025 (reference record read: four participants). Cell Press, Cambridge MA. Observation year 2025. Accessed 2026-11-03.back
  6. 8Chetty, N. et al., Signal properties and stability of a chronically implanted endovascular brain computer interface, medRxiv preprint, 25 September 2025 (preprint record read: five participants; 16-channel array; one year; not peer reviewed). Cold Spring Harbor Laboratory, New York. Observation year 2025. Accessed 2026-11-03.back
  7. 13ClinicalTrials.gov (ed.), PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices, NCT06429735 (record read: recruiting; start 9 January 2024; estimated enrolment 15; updated January 2026; sponsor-supplied entry). National Library of Medicine, Bethesda. Observation year 2026. Accessed 2026-11-03.back
  8. 20Zeff, M., Elon Musk Neuralink closes a USD 650 million Series E (trade report, 2 June 2025; page read; vendor statement as reported: five people implanted; valuation of about USD 9 billion pre-money from an earlier press report). TechCrunch, San Francisco. Observation year 2025. Accessed 2026-11-03.back
  9. 11United States Senate (ed.), Management of Individuals Neural Data Act of 2025 (MIND Act), S. 2925, 119th Congress, introduced text (text read: FTC study and report within one year of enactment; USD 10 million authorised; referred to committee). US Government Publishing Office, Washington. Observation year 2025. Accessed 2026-11-03.back
  10. 15Precision Neuroscience (ed.), company release on FDA 510(k) clearance of the Layer 7 Cortical Interface, 17 April 2025 (release read; vendor announcement, weak evidence: up to 30 days of implantation; 37 patients tested). Precision Neuroscience, New York. Observation year 2025. Accessed 2026-11-03.back
  11. 7Lorach, H. et al., Walking naturally after spinal cord injury using a brain-spine interface, Nature 618(7963), 126 to 133, published online 24 May 2023 (reference record read: fully implanted; stable for over one year; one man with chronic tetraplegia). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
  12. 9US Food and Drug Administration (ed.), Implanted Brain-Computer Interface (BCI) Devices for Patients with Paralysis or Amputation: Non-clinical Testing and Clinical Considerations, final guidance, May 2021 (guidance page read). Center for Devices and Radiological Health, Silver Spring. Observation year 2021. Accessed 2026-11-03.back
  13. 10UNESCO (ed.), Recommendation on the Ethics of Neurotechnology (page read: adopted November 2025 at the 43rd session of the General Conference; mandate entrusted by 194 Member States in 2023; the page states no neural data provisions). United Nations Educational, Scientific and Cultural Organization, Paris. Observation year 2025. Accessed 2026-11-03.back
  14. 16Ministry of Industry and Information Technology and six other bodies (eds.), Implementation Opinions on Promoting the Innovation and Development of the Brain-Computer Interface Industry, MIIT (2025) No. 164, 23 July 2025, English translation by the Center for Security and Emerging Technology, 18 December 2025 (translation page read). Georgetown University, Washington. Observation year 2025. Accessed 2026-11-03.back
  15. 14Colorado General Assembly (ed.), HB24-1058 Protect Privacy of Biological Data (bill page read: signed 17 April 2024; effective 7 August 2024). Colorado General Assembly, Denver. Observation year 2024. Accessed 2026-11-03.back
  16. 17Cornejo-Plaza, M.I., Cippitani, R. and Pasquino, V., Chilean Supreme Court ruling on the protection of brain activity: neurorights, personal data protection, and neurodata, Frontiers in Psychology 15, 27 February 2024 (reference record read). Frontiers Media, Lausanne. Observation year 2024. Accessed 2026-11-03.back
  17. 18Lee, B.H., Even Chile neurorights leave inferred mental data in a gray zone, Stanford Law School Law and Biosciences Blog, 27 April 2026 (blog page read; commentary, not a legal text). Stanford University, Stanford. Observation year 2026. Accessed 2026-11-03.back

Cite this annex

Valadbaygi, S. (Ed.). (2026). Annex B: Data appendix. In Exponential Technology Report 2026: Neurotechnology and Human–Machine Interfaces (Baseline Edition 2026, Report No. NR-XTECH-NEURO-GLOBAL-2026-BASELINE) [Draft under review]. The Global Centre for Risk and Innovation (GCRI).

Every citation form of the whole report, BibTeX and RIS included, is on the edition home. Cite this report

ReportsContribute

Send evidence or a correction on Neurotechnology and Human–Machine Interfaces.

Reports is the Consortium’s quarterly publication, written by six desks. This page sits with the GCRI Systems Evidence desk. What you know about this subject can become evidence, a case or a correction in the next edition, credited to you and published under CC BY 4.0 where it is your own work. Sent to the wrong desk, it is forwarded, not refused.

GCRI Systems Evidence deskExponential Technology

CC BY 4.0 Free to read. Text and figures: CC BY 4.0. Data: CC0 1.0. Authors keep copyright. Published by GCRI Canada.

The Global Centre for Risk and Innovation

Science · evidence · measurement

Not for profit

Our articles, maps and twins are free to read and free to republish. Readers and partners keep it that way.

Partner with us

Who funds us

GCRI is a not-for-profit institution. To ask who funds a piece of work, use the funding questions form.

Independence

Editors and the expert reviewers named on each article decide what we publish. Funders and partners do not review or approve articles before publication.

Licence

Articles: CC BY 4.0. Figures, maps, twins and data: CC BY 4.0. Other uses: ask through the permissions form.